-
Health Canada approves weight-loss drug for sleep apnea in patients with obesity
The department confirmed that the authorization granted on June 11 makes Zepbound the only GLP-1 drug in Canada approved for the sleep disorder that causes people to stop breathing temporarily because their upper airway is blocked.

